Summary:

"A continual increase in cases of Long/Post COVID constitutes a medical and socioeconomic challenge to health systems around the globe. While the true extent of this problem cannot yet be fully evaluated, recent data suggest that up to 20 % of people with confirmed SARS-CoV-2 suffer from clinically rele- vant symptoms of Long/Post COVID several weeks to months after the acute phase. The clinical presentation is highly variable with the main symptoms being chronic fatigue, dyspnea, and cognitive symptoms. Extracorporeal apheresis has been suggested to alleviate symptoms of Post/COVID. Thus, numerous patients are currently treated with apheresis. However, at present there is no data from randomized controlled trials avail- able to confirm the efficacy. Therefore, physicians rely on the experience of practitioners and centers performing this treatment..."

To PDF on external page:

Post COVID and Apheresis – Where are we Standing?

Horm Metab Res 2022; 54: 715–720 DOI 10.1055/a-1945-9694 ISSN 0018-5043 © 2022. Thieme. All rights reserved. Georg Thieme Verlag, Rüdigerstraße 14, 70469 Stuttgart, Germany

Authors of this publication:

Charlotte Steenblock1 , Romy Walther1, Sergey Tselmin1, Natalia Jarzebska1, 2, Karin Voit-Bak3, Nicole Toepfner4, Timo Siepmann5, Jens Passauer1, Christian Hugo1, Gloria Wintermann6, Ulrich Julius1, Mahmoud Barbir7, Tina Z. Khan7, Milo A. Puhan8, Richard Straube1, Bernd Hohenstein1, Stefan R. Bornstein1, 9, Roman N. Rodionov1, 2

Affiliations:

1. Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
2. University Center for Vascular Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
3. Zentrum für Apherese- und Hämofiltration am INUS Tagesklinikum, Cham, Germany
4. Department of Pediatrics, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
5. Department of Neurology, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
6. Department of Psychotherapy and Psychosomatic
   Medicine, University Hospital Carl Gustav Carus,
   Technische Universität Dresden, Dresden, Germany
7. Department of Cardiology, Harefield Hospital, Harefield,
   United Kingdom of Great Britain and Northern Ireland
8. Epidemiology, Biostatistics and Prevention Institute,
   University of Zurich, Zurich, Switzerland
9. School of Cardiovascular and Metabolic Medicine and
   Sciences, Faculty of Life Sciences & Medicine, King’s College London, London, United Kingdom of Great Britain and Northern Ireland